Instrument measurement of lingual force variability reflects tardive tongue dyskinesia

Journal of Medical Engineering and Technology

Volumn 34, Issue 1, 2010, Pages 71-77

  Koning, J P ^a,b   Tenback, D E ^a,c   Kahn, R S ^b,c   Van Schelven, L J ^c   Van Harten, P N ^a,d  

^a Psychiatric Centre Symfora Group   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Instrument assessment; Reliability; Tardive dyskinesia; Tongue; Validation

Indexed keywords

HEALTHY CONTROLS; INVOLUNTARY MOVEMENTS; PSYCHIATRIC DISORDERS; TEST-RETEST RELIABILITY;

RELIABILITY;

INSTRUMENTS;

NEUROLEPTIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSKINESIA; FEMALE; FORCE; HUMAN; MALE; MEASUREMENT; MOOD DISORDER; PERSONALITY DISORDER; PSYCHIATRIC DIAGNOSIS; RATING SCALE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; TARDIVE DYSKINESIA; TARDIVE TONGUE DYSKINESIA; TEST RETEST RELIABILITY; TONGUE DISEASE;

ANTIPSYCHOTIC AGENTS; CASE-CONTROL STUDIES; DYSKINESIA, DRUG-INDUCED; HUMANS; LOGISTIC MODELS; MOVEMENT; REPRODUCIBILITY OF RESULTS; STATISTICS, NONPARAMETRIC; TONGUE;

EID: 72049092676     PISSN: 03091902     EISSN: 1464522X     Source Type: Journal    
DOI: 10.3109/03091900903402105     Document Type: Article

References (37)

1. Marsalek, M., 2000, Tardive drug-induced extrapyramidal syndromes. Pharmacopsychiatry, 33 Suppl 1, 14-33.
2. Weiden, P.J., Mann, J.J., Haas, G., Mattson, M. and Frances, A., 1987, Clinical nonrecognition of neuroleptic-induced movement disorders: a cautionary study. American Journal of Psychiatry, 144, 1148-1153.
3. Bergen, J.A., Griffiths, D.A., Rey, J.M. and Beumont, P.J., 1984, Tardive dyskinesia: fluctuating patient or fluctuating rater. British Journal of Psychiatry, 144, 498-502.
4. Caligiuri, M.P., Harris, M.J. and Jeste, D.V. 1988, Quantitative analyses of voluntary orofacial motor control in schizophrenia and tardive dyskinesia. Biological Psychiatry, 24, 787-800.
5. Caligiuri, M.P. and Lohr, J.B., 1990, Fine force instability: a quantitative measure of neuroleptic-induced dyskinesia in the hand. Journal of Neuropsychiatry and Clinical Neurosciences, 2, 395-398.
6. Caligiuri, M.P. and Lohr, J.B., 1994, A disturbance in the control of muscle force in neuroleptic-naive schizophrenic patients. Biological Psychiatry, 35, 104-111.
7. Caligiuri, M.P., Lohr, J.B., Panton, D. and Harris, M.J., 1993, Extrapyramidal motor abnormalities associated with late-life psychosis. Schizophrenia Bulletin, 19, 747-754.
8. Caligiuri, M.P., Lohr, J.B., Rotrosen, J., Adler, L., Lavori, P., Edson, R. and Tracy, K., 1997, Reliability of an instrumental assessment of tardive dyskinesia: results from VA Cooperative Study #394. Psychopharmacology (Berlin), 132, 61-66.
9. Cortese, L., Caligiuri, M.P., Malla, A.K., Manchanda, R., Takhar, J. and Haricharan, R., 2005, Relationship of neuromotor disturbances to psychosis symptoms in first-episode neuroleptic-naive schizophrenia patients. Schizophrenia Research, 75, 65-75.
10. Dean, C.E., Russell, J.M., Kuskowski, M.A., Caligiuri, M.P. and Nugent, S.M. 2004, Clinical rating scales and instruments: how do they compare in assessing abnormal, involuntary movements? Journal of Clinical Psychopharmacology, 24, 298-304.
11. Gardos, G., Cole, J.O. and La Brie, R., 1977, The assessment of tardive dyskinesia. Archives of General Psychiatry, 34, 1206-1212.
12. Lane, R.D., Glazer, W.M., Hansen, T.E., Berman, W.H. and Kramer, S.I., 1985, Assessment of tardive dyskinesia using the Abnormal Involuntary Movement Scale. Journal of Nervous and Mental Disease, 173, 353-357.
13. Lohr, J.B. and Caligiuri, M.P., 1992, Quantitative instrumental measurement of tardive dyskinesia: a review. Neuropsychopharmacology, 6, 231-239.
14. Tenback, D.E., van Harten, P.N., Slooff, C.J., Belger, M.A. and van Os, J., 2005, Effects of antipsychotic treatment on tardive dyskinesia: a 6-month evaluation of patients from the European Schizophrenia Outpatient Health Outcomes (SOHO) Study. Journal of Clinical Psychiatry, 66, 1130-1133.
15. Margolese, H.C., Chouinard, G., Kolivakis, T.T., Beauclair, L., Miller, R. and Annable, L., 2005, Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 2: Incidence and management strategies in patients with schizophrenia. Canadian Journal of Psychiatry, 50, 703-714. (Pubitemid 43175488)
16. Mittal, V.A. and Walker, E.F., 2007, Movement abnormalities predict conversion to Axis I psychosis among prodromal adolescents. Journal of Abnormal Psychology, 116, 796-803.
17. Walker, E.F., 1994, Developmentally moderated expressions of the neuropathology underlying schizophrenia. Schizophrenia Bulletin, 20, 453-480.
18. Haroun, N., Dunn, L., Haroun, A. and Cadenhead, K.S., 2006, Risk and protection in prodromal schizophrenia: ethical implications for clinical practice and future research. Schizophrenia Bulletin, 32, 166-178.
19. Caligiuri, M.P., Lohr, J.B., Bracha, H.S. and Jeste, D.V., 1991, Clinical and instrumental assessment of neuroleptic-induced parkinsonism in patients with tardive dyskinesia. Biological Psychiatry, 29, 139-148.
20. Caligiuri, M.P., Lohr, J.B., Vaughan, R.M. and McAdams, L.A., 1995, Fluctuation of tardive dyskinesia. Biological Psychiatry, 38, 336-339.
21. Lohr, J.B. and Caligiuri, M.P., 1995, Motor asymmetry, a neurobiologic abnormality in the major psychoses. Psychiatry Research, 57, 279-282.
22. Jeste D.V. and Wyatt R.J., 1982, Understanding and Treating Dyskinesia (New York: Guilford).
23. McCreadie, R.G., Srinivasan, T.N., Padmavati, R. and Thara, R., 2005, Extrapyramidal symptoms in unmedicated schizophrenia. Journal of Psychiatric Research, 39, 261-266.
24. Mittal, V.A., Neumann, C., Saczawa, M. and Walker, E.F., 2008, Longitudinal progression of movement abnormalities in relation to psychotic symptoms in adolescents at high risk of schizophrenia. Archives of General Psychiatry, 65, 165-171.
25. Caligiuri, M.P., Jeste, D.V. and Harris, M.J., 1989, Instrumental assessment of lingual motor instability in tardive dyskinesia. Neuropsychopharmacology, 2, 309-312.
26. APA, 1994, Diagnostic and Statistical Manual of Mental Disorders (Washington, DC: American Psychiatric Association).
27. Guy, E., 1976, Abnormal Involuntary Movement Scale, ECDEU assessment manual for psychopharmacology, National Institute of Mental Health, US Department Health and Human Services.
28. Ondo, W.G., Hanna, P.A. and Jankovic, J., 1999, Tetrabenazine treatment for tardive dyskinesia: assessment by randomized videotape protocol. American Journal of Psychiatry, 156, 1279-1281.
29. Slotema, C.W., van Harten, P.N., Bruggeman, R. and Hoek, H.W., 2008, Botulinum toxin in the treatment of orofacial tardive dyskinesia: a single blind study. Progress in Neuropsychopharmacology and Biological Psychiatry, 32, 507-509.
30. Stein, R.B. and Oguztoreli, M.N., 1976, Tremor and other oscillations in neuromuscular systems. Biological Cybernetics, 22, 147-157.
31. Ho, B.C., Mola, C. and Andreasen, N.C., 2004, Cerebellar dysfunction in neuroleptic naive schizophrenia patients: clinical, cognitive, and neuroanatomic correlates of cerebellar neurologic signs. Biological Psychiatry, 55, 1146-1153.
32. Boks, M.P., Russo, S., Knegtering, R. and van den Bosch, R.J., 2000, The specificity of neurological signs in schizophrenia: a review. Schizophrenia Research, 43, 109-116.
33. Buchanan, R.W. and Heinrichs, D.W., 1989, The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signsinschizophrenia.PsychiatryResearch,27,335-350.
34. King, D.J., Wilson, A., Cooper, S.J. and Waddington, J.L., 1991, The clinical correlates of neurological soft signs in chronic schizophrenia. British Journal of Psychiatry, 158, 770-775.
35. Gupta, S., Andreasen, N.C., Arndt, S., Flaum, M., Schultz, S.K., Hubbard, W.C. and Smith, M., 1995, Neurological soft signs in neuroleptic-naive and neuroleptic-treated schizophrenic patients and in normal comparison subjects. American Journal of Psychiatry, 152, 191-196.
36. Lauterbach, E.C., Carter, W.G., Rathke, K.M., Thomas, B.H., Shillcutt, S.D., Vogel, R.L., Moore, N.C., Mimbs, J.W. and Nelson, W.H., 2001, Tardive dyskinesia-diagnostic issues, subsyndromes, and concurrent movement disorders: a study of state hospital inpatients referred to a movement disorder consultation service. Schizophrenia Bulletin, 27, 601-613.
37. van Harten, P.N., Hoek, H.W., Matroos, G.E. and van Os, J., 2006, Incidence of tardive dyskinesia and tardive dystonia in African Caribbean patients on long-term antipsychotic treatment: the Curacao extrapyramidal syndromes study V. Journal of Clinical Psychiatry, 67, 1920-1927.